Global Source Ventures
Global Source Ventures provides capital, management and advisory services to early-stage life sciences companies with disruptive technologies that have the potential to substantially improve the conditions of life. Their international network includes investors, investment bankers, financial analysts, leading scientific experts, and industry contacts. Their managing partners have a proven track record of securing funding, setting strategy and building successful organizations that have historically produced favorable returns for investors. GSV maintains an ownership interest in its portfolio companies through a combination of equity investments, convertible notes, stock options and warrants.
SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune diseases and selecting cancer indications by targeting autoreactive, chronically activated T cells. It has established a technology platform to develop potent and highly selective peptide blockers for ion channels involved in various diseases. Its platform enables to optimize the target selectivity, providing the opportunity to develop drugs with significantly improved efficacy and safety profiles.
Oncternal Therapeutics is a clinical-stage oncology company developing first-in-class and novel therapies for both rare and common cancers. Their pipeline has recently expanded and now includes two clinical-stage products with common regulatory and development strategies. Oncternal Therapeutics cutting-edge scientific approach is focused on targets that are uniquely expressed within cancer cells, resulting in highly targeted new therapies. They also apply a variety of therapeutic strategies to address different medical challenges - from antibodies and antibody-drug conjugates (ADCs) to small molecules and chimeric antigen receptor T-cells (CAR-T).
Zavante is a clinical-stage biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.